Table 1 Clinical characteristics of patients according to 4-miRNA signatures from GC training and testing sets.
From: Prognostic Value of microRNA Signature in Patients with Gastric Cancers
Variable | n | The 4-miRNA signature | p value | |
---|---|---|---|---|
Higher risk | Lower risk | |||
Age (years) |  |  |  | p = 0.0333 |
<60.5 | 51 | 15 | 36 | Â |
≥60.5 | 51 | 24 | 27 |  |
Gender |  |  |  | p = 0.1143 |
male | 89 | 36 | 53 | Â |
female | 13 | 3 | 10 | Â |
Tumor size (cm) |  |  |  | p = 0.3535 |
<4.6 | 42 | 16 | 26 | Â |
≥4.6 | 55 | 23 | 32 |  |
Missing | 5 | 0 | 5 | Â |
T classification |  |  |  | p = 0.0161 |
T1 | 10 | 1 | 9 | Â |
T2 | 53 | 17 | 36 | Â |
T3 | 33 | 19 | 14 | Â |
T4 | 3 | 2 | 1 | Â |
Missing | 3 | 0 | 3 | Â |
Lymph node metastasis |  |  |  | p = 0.0003 |
N0 | 35 | 4 | 31 | Â |
N1 | 44 | 25 | 19 | Â |
N2 | 14 | 6 | 8 | Â |
N3 | 6 | 4 | 2 | Â |
Missing | 3 | 0 | 3 | Â |
Distant metastasis (M) |  |  |  | p = 0.1633 |
Negative (M0) | 68 | 29 | 39 | Â |
Positive (M1) | 31 | 10 | 21 | Â |
Missing | 3 | 0 | 3 | Â |
Differentiation |  |  |  | p = 0.5697 |
well | 3 | 2 | 1 | Â |
moderate | 31 | 11 | 20 | Â |
poor | 67 | 26 | 41 | Â |
Missing | 1 | 0 | 1 | Â |